Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009

· Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis